Trials / Completed
CompletedNCT07080853
Acute Exercise With Overdressing
Efficacy of a Novel Exercise + Overdressing Protocol to Induce Targeted Heat Stress in Temperate Environments (Acute XO-Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- United States Army Research Institute of Environmental Medicine · Federal
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if exercise with extra clothing in a gym-like environment can increase body temperatures appropriately to help people adapt to the heat.
Detailed description
The purpose of the present study is to examine the influence of a novel 90-minute exercise + overdressing protocol on thermal responses in comparison to matched exercise in standard PT clothing. Sixteen healthy and fit adults (8 men and 8 women) will complete two 90-minute exercise sessions (randomized order) in a temperate environment (\~20°C, \~50% relative humidity, and \~1 mph air velocity) involving a 30-minute run immediately followed by a 60-minute walk. Participants will wear standard physical training (PT) clothing (shorts, t-shirt) during one session and an overdressing ensemble in the other. The investigators hypothesize that 1) exercise + overdressing will elevate core temperature to between 38.3°C and 39.3°C for at least 45 minutes; and 2) elevations in core temperature, skin temperature, heart rate, and sweat rate will be substantially larger than observed with 90 minutes of matched exercise in standard PT clothing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Exercise with Overdressing | Run for 30 minutes followed by walk for 60 minutes in a temperate (gym-like environment) wearing overdressing ensemble. |
| OTHER | Control Exercise | Run for 30 minutes followed by walk for 60 minutes in a temperate (gym-like environment) wearing control clothing ensemble. |
Timeline
- Start date
- 2023-06-22
- Primary completion
- 2025-04-28
- Completion
- 2025-04-28
- First posted
- 2025-07-23
- Last updated
- 2025-12-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07080853. Inclusion in this directory is not an endorsement.